Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)
China flag China · Delayed Price · Currency is CNY
4.270
+0.070 (1.67%)
Feb 4, 2026, 3:00 PM CST

SHA:600488 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
2,8493,1903,7553,6663,7353,106
Other Revenue
25.7625.7627.4822.5613.3510.65
2,8753,2153,7833,6893,7493,117
Revenue Growth (YoY)
-18.27%-15.00%2.54%-1.59%20.27%-6.31%
Cost of Revenue
1,6891,7962,0791,9332,0161,734
Gross Profit
1,1861,4191,7041,7561,7321,383
Selling, General & Admin
819.47930.581,3371,3941,3851,054
Research & Development
154.41199.87157.67139.45128.87131.83
Other Operating Expenses
14.318.5329.4440.940.1518.77
Operating Expenses
988.671,1491,5241,5751,5541,205
Operating Income
197.11269.96179.93181.37178.2178.02
Interest Expense
-21.24-28.82-36.69-48.16-45.91-40.19
Interest & Investment Income
11.098.128.574.427.082.29
Currency Exchange Gain (Loss)
13.6713.6711.8316.281.37-3.29
Other Non Operating Income (Expenses)
-80.72-1.18-0.92-1.86-2.54-23.32
EBT Excluding Unusual Items
119.92261.76162.72152.05138.21113.51
Gain (Loss) on Sale of Investments
-8.66-9.09-1.13-22.44--1.22
Gain (Loss) on Sale of Assets
0.72-0.10.65-0.99-0.06-0.21
Asset Writedown
-21.18-34.56-8.18-73.02-4.37-
Other Unusual Items
8.58.514.18-43.115.290.3
Pretax Income
99.3226.51168.2412.52149.07112.38
Income Tax Expense
17.6618.35.57-5.9240.431.8
Earnings From Continuing Operations
81.64208.21162.6718.44108.6780.58
Minority Interest in Earnings
-65.35-74.76-45.6216.97-60-46.6
Net Income
16.3133.45117.0535.4148.6733.98
Net Income to Common
16.3133.45117.0535.4148.6733.98
Net Income Growth
-89.28%14.01%230.60%-27.25%43.23%-79.00%
Shares Outstanding (Basic)
1,0901,0941,0941,1061,0821,096
Shares Outstanding (Diluted)
1,0901,0941,0941,1061,0821,096
Shares Change (YoY)
-0.37%-0.01%-1.13%2.31%-1.33%0.28%
EPS (Basic)
0.010.120.110.030.040.03
EPS (Diluted)
0.010.120.110.030.040.03
EPS Growth
-89.24%14.02%234.38%-28.89%45.16%-79.05%
Free Cash Flow
79.18491.63649.86451.33-53.95-111.63
Free Cash Flow Per Share
0.070.450.590.41-0.05-0.10
Dividend Per Share
0.0980.0980.0870.0100.0140.010
Dividend Growth
12.64%12.64%770.00%-28.57%40.00%-75.00%
Gross Margin
41.25%44.13%45.04%47.61%46.21%44.36%
Operating Margin
6.86%8.40%4.76%4.92%4.75%5.71%
Profit Margin
0.57%4.15%3.09%0.96%1.30%1.09%
Free Cash Flow Margin
2.76%15.29%17.18%12.23%-1.44%-3.58%
EBITDA
499.92559.08450.78438.18383.2361.77
EBITDA Margin
17.39%17.39%11.92%11.88%10.22%11.61%
D&A For EBITDA
302.82289.12270.85256.81205183.75
EBIT
197.11269.96179.93181.37178.2178.02
EBIT Margin
6.86%8.40%4.76%4.92%4.75%5.71%
Effective Tax Rate
17.79%8.08%3.31%-27.10%28.30%
Revenue as Reported
2,8753,2153,7833,6893,7493,117
Advertising Expenses
-249.58543.79645.43650.67416.15
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.